3-Hydroxypicolinic acid
CAS No. 874-24-8
3-Hydroxypicolinic acid( Picolinic acid 3-hydroxy- (6CI7CI8CI) | 2-Carboxy-3-hydroxypyridine )
Catalog No. M20615 CAS No. 874-24-8
3-Hydroxypicolinic acid is a picolinic acid derivative and belongs to the pyridine family.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 35 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Hydroxypicolinic acid
-
NoteResearch use only, not for human use.
-
Brief Description3-Hydroxypicolinic acid is a picolinic acid derivative and belongs to the pyridine family.
-
Description3-Hydroxypicolinic acid is a picolinic acid derivative and belongs to the pyridine family.
-
In Vitro——
-
In Vivo——
-
SynonymsPicolinic acid 3-hydroxy- (6CI7CI8CI) | 2-Carboxy-3-hydroxypyridine
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874-24-8
-
Formula Weight139.11
-
Molecular FormulaC6H5NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:28 mg/mL (201.27 mM)
-
SMILESOC(=O)c1ncccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Aflatoxin B1
Aflatoxin B1 (AFB1) is a Group 1A carcinogen and a secondary metabolite produced by Aspergillus flavus and A. parasiticus. Aflatoxin B1 (AFB1) primarily induces mutations by causing a G to T transversion at the third nucleotide of codon 249 in the tumor suppressor gene p53. In the body, Aflatoxin B1 (AFB1) can cause damage to the intestines and kidneys and has some teratogenic effects.
-
1,3-Dihydroxyacetone
1,3-Dihydroxyacetone is the main active ingredient in sunscreen tanning skin care preparations, an important precursor for the synthesis of a variety of fine chemicals, and a food additive that can be produced on an industrial scale by microbial fermentation on Gluconobacter oxydans.
-
3-Hydroxyglutaric ac...
3-Hydroxyglutaric acid is one of several metabolites produced when insufficient levels of GCDH are available. It is used as a biomarker of GCDH deficiency.
Cart
sales@molnova.com